Skip to main content

Table 2 Clinical outcomes per group (mean ± SD)

From: Follicular fluid biomarkers for prediction of human IVF outcome in women with poor ovarian response

Variable

Group A

Group B

Group C

p-value

Total number of captured oocytes

9.1 ± 6.03

10.45 ± 6.22

6.45 ± 2.95

0.07

MII oocytes

5.5 ± 5.04

6.45 ± 4.41

4 ± 3.09

0.21

MI oocytes

1.7 ± 2.08

1.9 ± 1.29

0.85 ± 0.88

0.057

Prophase I

0.9 ± 1.92

0.8 ± 1.47

0.45 ± 1.05

0.42

Degenerated oocytes

1.45 ± 2.44

1.3 ± 2.03

1.15 ± 2.03

0.94

Number of ICSI injected oocytes

7.6 ± 4.41

9.9 ± 5.8

9.35 ± 4.85

0.33

Number of fertilized oocytes

5.8 ± 3.79

7.7 ± 5.62

7.1 ± 4.25

0.50

Number of two pronuclei oocytes

5.55 ± 3.58

7.55 ± 5.12

6.5 ± 4.54

0.40

Day 3 embryos

5.35 ± 3.42

6.75 ± 3.92

6.3 ± 3.93

0.52

Average number of cells on day 3

6.44 ± 1.38

6.69 ± 1.08

6.21 ± 1.92

0.78

Mean embryo quality on day 3

3.08 ± 0.25

2.98 ± 0.07

2.87 ± 0.87

0.21

Blastocyst number on day 5

2.45 ± 2.65

2.8 ± 2.21

3 ± 2.32

0.48

Blastocyst mean quality on day 5

2.3 ± 1.59

2.87 ± 1.29

2.86 ± 2.07

0.35

Transferred embryos on day 5

0.9 ± 1.02

1.1 ± 0.91

0.85 ± 0.75

0.65

  1. Statistically significant p-values were marked in bold (α ≤ 0.05). aVariables were represented with mean ± SD. bQualitative variables were represented with absolute and relative frequencies; the p-value was calculated using a chi-square test